General Information of Drug (ID: DM4AX65)

Drug Name
ARO-MUC5AC Drug Info
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM4AX65

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mucin-5AC messenger RNA (MUC5AC mRNA) TTTLE0A MUC5A_HUMAN Inhibitor [1]

References

1 ClinicalTrials.gov (NCT05292950) A Phase 1/2a Study Evaluating the Effects of ARO-MUC5AC Inhalation Solution in Healthy Subjects and Patients With Muco-Obstructive Lung Disease. U.S.National Institutes of Health.